Author name: Ingrid Posadas

Leadership & Founders, Press Release, Uncategorized

Opinion: DMD Gene Therapy’s Inflection Point and the Case for Small Molecules

Leave a Comment / Leadership & Founders, Press Release, Uncategorized / Ingrid Posadas

Originally published on BioSpace iStock, alexkich As AAV9 and CRISPR programs navigate safety, delivery and scalability hurdles, small molecules offer a […]

Press Release

Sarcomatrix Secures $300K Investment from Nevada’s State-Sponsored Venture Capital Program, Battle Born Venture

Leave a Comment / Press Release / Ingrid Posadas

Funding to speed development of next‑generation treatments for Duchenne muscular dystrophy. RENO, NV, UNITED STATES, August 22,2025 /EINPresswire.com/ —Sarcomatrix Therapeutics,

Invest in a Better Tomorrow

Together, We Can Cure Muscle-Wasting Diseases

Your investment can help us accelerate pre-clinical research and move on to in-human trials so we can start offering treatments as soon as possible.